𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B

✍ Scribed by Serap Emre; Mugen Terzioglu; Aysegul Tokatli; Turgay Coskun; Imran Ozalp; Birgit Weber; John J. Hopwood


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
38 KB
Volume
19
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Sanfilippo syndrome (mucopolysaccharidosis type III, MPS III) is a progressive disorder in which patients are characterized by severe central nervous system degeneration together with mild somatic disease. MPS III results from a deficiency in one of the four enzymes involved in the degradation of heparan sulfate, with sulfamidase (SGSH) being deficient in MPS IIIA and Ξ± Ξ± -N-acetylglucosaminidase (NAGLU) deficient in MPS IIIB. Mutation screening using SSCP/heteroduplex analysis on genomic DNA fragments was performed in five Turkish MPS IIIA and eight Turkish MPS IIIB patients. In this study two mutations of SGSH were identified in MPS IIIA patients: R74C and the novel mutation P288S, and one polymorphism (IVS1+23 C>G). Five different mutations of NAGLU were identified in MPS IIIB patients: L682R, H248R, E153K, g.17703 A>G (novel), and T437I (novel). The clinical data of all patients are reported in detail. A high degree of genetic heterogeneity was observed in the Turkish MPS IIIA and MPS IIIB patients.


πŸ“œ SIMILAR VOLUMES


Identification of molecular defects in I
✍ Paola Di Natale; Nicola Balzano; Sabrina Esposito; Guglielmo R. D. Villani πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 220 KB πŸ‘ 1 views

Sanfilippo syndrome type A or mucopolysaccharidosis IIIA (MPS IIIA) is a lysosomal storage disorder caused by the deficiency of the enzyme heparin sulfamidase (EC 3.10.1.1), required for the degradation of the mucopolysaccharide heparan sulfate. Patients develop central nervous system degeneration r

Identification and functional analysis o
✍ Asma Chaoui; Yuli Watanabe; Renaud Touraine; Viviane Baral; Michel Goossens; Ver πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 659 KB

Waardenburg syndrome (WS) is a rare disorder characterized by pigmentation defects and sensorineural deafness, classified into four clinical subtypes, WS1-S4. Whereas the absence of additional features characterizes WS2, association with Hirschsprung disease defines WS4. WS is genetically heterogene

Identification of novel mutations in WFS
✍ A. Cano; C. Rouzier; S. Monnot; B. Chabrol; J. Conrath; P. Lecomte; B. Delobel; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 2 views

## Abstract Mutations in the __WFS1__ gene have been reported in Wolfram syndrome (WS), an autosomal recessive disorder defined by early onset of diabetes mellitus (DM) and progressive optic atrophy. Because of the low prevalence of this syndrome and the recent identification of the __WFS1__ gene,

Identification of novel mutations in pat
✍ Elena Nicolis; Alberto Bonizzato; Baroukh M. Assael; Marco Cipolli πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

## Communicated by Mireille Claustres Shwachman-Diamond syndrome (SDS) is a rare autosomal recessive disease, mainly characterized by exocrine pancreatic insufficiency, hematological dysfunction and skeletal abnormalities. The SDS disease locus was mapped to chromosome 7q11 and disease-associated m

HHV-8 subtypes in South Africa: Identifi
✍ Florette K. Treurnicht; Susan Engelbrecht; Maureen B. Taylor; Johan W. Schneider πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

## Abstract Human herpesvirus 8 (HHV‐8) has been identified as the causative agent for all forms of Kaposi's sarcoma and is also associated with the development of body cavity‐based B‐cell lymphomas and multicentric Castleman's disease. HHV‐8 genomes are now classified into five major subtypes (A–E